BioCentury | Aug 26, 2020
Product Development

Sizing up Ovid’s soticlestat among Dravet therapies

...million through the sale of 6.25 million shares at $8 in a follow-on underwritten by Cowen, William Blair...
BioCentury | Jul 10, 2020
Finance

Nkarta’s $252M IPO among biggest preclinical listings ever

...halt during the day ahead of NASDAQ trading. Poseida’s were BofA Securities, Piper Sandler and William Blair...
BioCentury | Dec 12, 2019
Financial News

Momenta, Forty Seven, Assembly push 2019 follow-on tally to $21.5B

...buy up to 2.4 million shares at $16.499 a share. Underwriters were Jefferies, SVB Leerink, William Blair...
BioCentury | Oct 2, 2019
Financial News

Three new IPO filings broaden fall queue

...Scientific Adviser David Schaffer, while Pfizer Inc. (NYSE:PFE) holds 11.8%. Underwriters are Goldman Sachs, Evercore, William Blair...
BioCentury | Sep 23, 2019
Financial News

Fall IPO flurry as biotechs ramp up listing timelines

...Monday with a market cap of about $211 million. Underwriters are Cowen, Cantor Fitzgerald and William Blair...
BioCentury | Aug 27, 2019
Financial News

Aug. 27 Financial Quick Takes: Prothena gains on EcoR1 investment; plus Pharmaron, Exagen

...week to raise up to $57.5 million in an IPO underwritten by Cowen, Cantor and William Blair...
BioCentury | Aug 23, 2019
Company News

Aug. 23 Company Quick Takes: Amgen-Alexion, Lilly-Adocia, Gilead-Galapagos

...that Amgen is close to acquiring the rare disease drug developer at $200 per share. William Blair...
BioCentury | Jul 2, 2019
Financial News

July 2 Financial Quick Takes: Suspension continues for Woodford fund; plus CRUK, Codiak and Amarin

...listing in late April, but never set terms. Underwriters were to be Jefferies, Evercore ISI, William Blair...
BioCentury | Jun 27, 2019
Financial News

June 26 Financial Quick Takes: Adaptive prices upsized IPO; plus BridgeBio, Medicines Co., Global Blood, Odonate

...million shares at $15-$17. Underwriters are Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Cowen, Guggenheim, William Blair...
BioCentury | Jun 19, 2019
Financial News

June 19 Financial Quick Takes: Stoke rises after IPO; plus Polaris, Woodford, follow-ons

...from their early June peak of $67.86. Underwriters are Goldman Sachs, Piper Jaffray, Cantor Fitzgerald, William Blair...
...Tuesday, and slipped another $0.65 (14%) to $4.09 on Wednesday. SVB Leerink, Wells Fargo and William Blair...
Items per page:
1 - 10 of 674
BioCentury | Aug 26, 2020
Product Development

Sizing up Ovid’s soticlestat among Dravet therapies

...million through the sale of 6.25 million shares at $8 in a follow-on underwritten by Cowen, William Blair...
BioCentury | Jul 10, 2020
Finance

Nkarta’s $252M IPO among biggest preclinical listings ever

...halt during the day ahead of NASDAQ trading. Poseida’s were BofA Securities, Piper Sandler and William Blair...
BioCentury | Dec 12, 2019
Financial News

Momenta, Forty Seven, Assembly push 2019 follow-on tally to $21.5B

...buy up to 2.4 million shares at $16.499 a share. Underwriters were Jefferies, SVB Leerink, William Blair...
BioCentury | Oct 2, 2019
Financial News

Three new IPO filings broaden fall queue

...Scientific Adviser David Schaffer, while Pfizer Inc. (NYSE:PFE) holds 11.8%. Underwriters are Goldman Sachs, Evercore, William Blair...
BioCentury | Sep 23, 2019
Financial News

Fall IPO flurry as biotechs ramp up listing timelines

...Monday with a market cap of about $211 million. Underwriters are Cowen, Cantor Fitzgerald and William Blair...
BioCentury | Aug 27, 2019
Financial News

Aug. 27 Financial Quick Takes: Prothena gains on EcoR1 investment; plus Pharmaron, Exagen

...week to raise up to $57.5 million in an IPO underwritten by Cowen, Cantor and William Blair...
BioCentury | Aug 23, 2019
Company News

Aug. 23 Company Quick Takes: Amgen-Alexion, Lilly-Adocia, Gilead-Galapagos

...that Amgen is close to acquiring the rare disease drug developer at $200 per share. William Blair...
BioCentury | Jul 2, 2019
Financial News

July 2 Financial Quick Takes: Suspension continues for Woodford fund; plus CRUK, Codiak and Amarin

...listing in late April, but never set terms. Underwriters were to be Jefferies, Evercore ISI, William Blair...
BioCentury | Jun 27, 2019
Financial News

June 26 Financial Quick Takes: Adaptive prices upsized IPO; plus BridgeBio, Medicines Co., Global Blood, Odonate

...million shares at $15-$17. Underwriters are Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Cowen, Guggenheim, William Blair...
BioCentury | Jun 19, 2019
Financial News

June 19 Financial Quick Takes: Stoke rises after IPO; plus Polaris, Woodford, follow-ons

...from their early June peak of $67.86. Underwriters are Goldman Sachs, Piper Jaffray, Cantor Fitzgerald, William Blair...
...Tuesday, and slipped another $0.65 (14%) to $4.09 on Wednesday. SVB Leerink, Wells Fargo and William Blair...
Items per page:
1 - 10 of 674